Jean-Pierre Lotz - JoVE Visualize

Showing results (11-20 of 82) with videos related to

Pageof 9

Sort By:

Bulletin Du Cancer|September 13, 2007

[Updates on gemcitabine on metastatic breast cancer]Joseph Gligorov, Fréderic Selle, Ahmed Khalil, et al.

Bulletin Du Cancer|May 28, 2019

[Impact of a coordinated regional organization to secure the management of patients on oral anticancer drugs: CHIMORAL, a comparative trial]Christophe Maritaz, Nathalie Gault, Carine Roy, et al.

European Journal of Nuclear Medicine and Molecular Imaging|May 8, 2004

[18F]FDG in recurrent breast cancer: diagnostic performances, clinical impact and relevance of induced changes in managementDany Grahek, Françoise Montravers, Khaldoun Kerrou, et al.

Anais Da Academia Brasileira De Ciencias|June 9, 2016

Pertuzumab and trastuzumab: the rationale way to synergySandrine Richard, Frédéric Selle, Jean-Pierre Lotz, et al.

Journal of Chemotherapy (Florence, Italy)|August 19, 2016

Trabectedin for sarcomas in daily clinical practice: analysis of 45 patients treated in a French institutionJohanne Daupin, Pascal Paubel, Julie Fillon, et al.

Clinical Chemistry|June 25, 2005

Evaluation of the quantitative analytical methods real-time PCR for HER-2 gene quantification and ELISA of serum HER-2 protein and comparison with fluorescence in situ hybridization and immunohistochemistry for determining HER-2 status in breast cancer patientsChantal Tse, Didier Brault, Joseph Gligorov, et al.

Oxford Medical Case Reports|May 6, 2017

Long-term complete response in a breast cancer patient with skeletal muscle metastases diagnosed using 18F-FDG-PETDiana Bello-Roufai, Daniele G Soares, Khaldoun Kerrou, et al.

Bulletin Du Cancer|January 6, 2009

[Anticancer chemotherapy in the elderly: a review of the literature]Isabelle Debrix, Danièle Avenin, Thierry André, et al.

American Journal of Obstetrics and Gynecology|February 2, 2016

Predictive factors of relapse in low-risk gestational trophoblastic neoplasia patients successfully treated with methotrexate aloneFlorence Couder, Jérôme Massardier, Benoît You, et al.

Bulletin Du Cancer|September 9, 2025

[Oncologists and hematologists' perspective on advance directives. A French national survey]Amélie Cambriel, Kevin Serey, Adrien Pollina-Bachellerie, et al.

Pageof 9

Showing results (11-20 of 82) with videos related to

Sort By:

Pageof 9

Bulletin Du Cancer|September 13, 2007

[Updates on gemcitabine on metastatic breast cancer]Joseph Gligorov, Fréderic Selle, Ahmed Khalil, et al.

Bulletin Du Cancer|May 28, 2019

[Impact of a coordinated regional organization to secure the management of patients on oral anticancer drugs: CHIMORAL, a comparative trial]Christophe Maritaz, Nathalie Gault, Carine Roy, et al.

European Journal of Nuclear Medicine and Molecular Imaging|May 8, 2004

[18F]FDG in recurrent breast cancer: diagnostic performances, clinical impact and relevance of induced changes in managementDany Grahek, Françoise Montravers, Khaldoun Kerrou, et al.

Anais Da Academia Brasileira De Ciencias|June 9, 2016

Pertuzumab and trastuzumab: the rationale way to synergySandrine Richard, Frédéric Selle, Jean-Pierre Lotz, et al.

Journal of Chemotherapy (Florence, Italy)|August 19, 2016

Trabectedin for sarcomas in daily clinical practice: analysis of 45 patients treated in a French institutionJohanne Daupin, Pascal Paubel, Julie Fillon, et al.

Clinical Chemistry|June 25, 2005

Evaluation of the quantitative analytical methods real-time PCR for HER-2 gene quantification and ELISA of serum HER-2 protein and comparison with fluorescence in situ hybridization and immunohistochemistry for determining HER-2 status in breast cancer patientsChantal Tse, Didier Brault, Joseph Gligorov, et al.

Oxford Medical Case Reports|May 6, 2017

Long-term complete response in a breast cancer patient with skeletal muscle metastases diagnosed using 18F-FDG-PETDiana Bello-Roufai, Daniele G Soares, Khaldoun Kerrou, et al.

Bulletin Du Cancer|January 6, 2009

[Anticancer chemotherapy in the elderly: a review of the literature]Isabelle Debrix, Danièle Avenin, Thierry André, et al.

American Journal of Obstetrics and Gynecology|February 2, 2016

Predictive factors of relapse in low-risk gestational trophoblastic neoplasia patients successfully treated with methotrexate aloneFlorence Couder, Jérôme Massardier, Benoît You, et al.

Bulletin Du Cancer|September 9, 2025

[Oncologists and hematologists' perspective on advance directives. A French national survey]Amélie Cambriel, Kevin Serey, Adrien Pollina-Bachellerie, et al.

Pageof 9